Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
|
US |
|
Lynas Rare Earths Ltd
XMUN:LYI
|
AU |
|
A
|
Atoss Software AG
XMUN:AOF
|
DE |
|
Westpac Banking Corp
ASX:WBC
|
AU |
|
N
|
NVIDIA Corp
F:NVD
|
US |
|
Yamaha Motor Co Ltd
TSE:7272
|
JP |
|
Organovo Holdings Inc
NASDAQ:VIVS
|
US |
|
E
|
Estee Lauder Companies Inc
DUS:ELAA
|
US |
|
Coeur Mining, Inc
TSX:CDE
|
US |
|
M&T Bank Corp
F:MTZ
|
US |
|
Seadrill Ltd
F:P4F
|
BM |
|
Inficon Holding AG
SIX:IFCN
|
CH |
|
R
|
Robert Half Inc
DUS:RHJ
|
US |
|
Surefire Resources NL
ASX:SRN
|
AU |
|
O
|
OMS Energy Technologies Inc
NASDAQ:OMSE
|
SG |
|
R
|
Riley Exploration Permian Inc
AMEX:REPX
|
US |
|
Ford Motor Co
NYSE:F
|
US |
|
Woolworths Holdings Ltd
OTC:WLWHF
|
ZA |
|
H
|
Heng Leasing and Capital PCL
SET:HENG
|
TH |
|
W
|
Westpac Banking Corp
XMUN:WBC
|
AU |
Wall St Price Targets
RYTM Price Targets Summary
Rhythm Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
RYTM is 140.96 USD with a low forecast of 106.05 USD and a high forecast of 166.95 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RYTM's stock price target?
Price Target
140.96
USD
According to Wall Street analysts, the average 1-year price target for
RYTM is 140.96 USD with a low forecast of 106.05 USD and a high forecast of 166.95 USD.
What is the Revenue forecast for Rhythm Pharmaceuticals Inc?
Projected CAGR
41%
The compound annual growth rate for Revenue over the next 8 years is 41%.